The Recall Desk
SevereFDA (Drugs)·D-0309-2017·Announced 2017-01-11

Tri-Coast Pharmacy Recalls TriMix Injection Due to Sterility Concerns

Tri-Coast Pharmacy is recalling 17 vials of TriMix injection because the agency could not ensure the products were sterile.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric for significant injury or property damage reports.

Plain-English summary

Tri-Coast Pharmacy is recalling 17 vials of TriMix, a compounded medication containing alprostadil, phentolamine, and papaverine. The recall was initiated due to a lack of assurance of sterility for the affected products.

The recall includes all sterile products compounded by the pharmacy between May 17, 2016, and November 17, 2016. Specific lot codes identified in the recall are 05312016D, 08162016F, 08312016C, and 08032016E. The products were distributed nationwide.

Consumers who possess these products should stop using them and contact their healthcare provider or the pharmacy for further instructions.

The recalled product

Product
TriMix, Alprostadil/Phentolamine/Papaverine 40mcg/2mg/30mg/mL, (1 ML). Compounded by Tri-Coast Pharmacy
Manufacturer
Tri-Coast Pharmacy
Hazard
Affected units
17

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • 08162016F (09/18/2016)
  • 08312016C (09/29/2016)
  • 08032016E (09/16/2016).

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 80 recalled by Tri-Coast Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 80 products in this recall →